Assessment and rehabilitation of cognitive impairment in multiple sclerosis

International Review of Psychiatry

Volumn 22, Issue 1, 2010, Pages 22-34

  Messinis, Lambros ^a   Kosmidis, Mary H ^b   Lyros, Epameinondas ^a   Papathanasopoulos, Panagiotis ^a  

^a UNIVERSITY OF PATRAS   (Greece)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; AMPHETAMINE; BETA1A INTERFERON; CHOLINESTERASE; CYCLOPHOSPHAMIDE; DONEPEZIL; GALANTAMINE; GINKGO BILOBA EXTRACT; GLATIRAMER; INTERFERON BETA SERINE; METHYLPREDNISOLONE; RIVASTIGMINE;

CLINICAL FEATURE; CLINICAL TRIAL; COGNITIVE DEFECT; COGNITIVE REHABILITATION; COMORBIDITY; DISEASE CLASSIFICATION; DISEASE COURSE; HUMAN; KINESIOTHERAPY; LIFESTYLE MODIFICATION; MULTIPLE SCLEROSIS; NEUROPSYCHOLOGICAL TEST; NEUROPSYCHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PATIENT SELECTION; PREVALENCE; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; REVIEW; SCREENING TEST; TREATMENT INDICATION;

CLINICAL TRIALS AS TOPIC; COGNITION; COGNITION DISORDERS; DISEASE PROGRESSION; HUMANS; IMMUNOLOGIC FACTORS; MULTIPLE SCLEROSIS; NEUROPSYCHOLOGICAL TESTS; PREVALENCE; PSYCHIATRIC STATUS RATING SCALES;

EID: 77951467928     PISSN: 09540261     EISSN: 13691627     Source Type: Journal    
DOI: 10.3109/09540261003589372     Document Type: Review

References (86)

1. Amato, M. P., Ponziani, G., Siracusa, G., & Sorbi, S. (2001). Cognitive dysfunction in early-onset multiple sclerosis: A reappraisal after 10 years. Archives of Neurology, 58, 1602-1606.
2. Amato, M. P., Zipoli, V., & Portaccio, E. (2006). Multiple sclerosis related cognitive changes: A review of cross-sectional and longitudinal studies. Journal of the Neurological Sciences, 245, 41-46.
3. Audoin, B., Ibarrola, D., Ranjeva, J. P., Confort-Gouny, S., Malikova, I., Ali-Chérif, A. et al. (2003). Compensatory cortical activation observed by fMRI during a cognitive task at the earliest stage of MS. Human Brain Mapping, 20, 51-58.
4. Baddeley, A. (1992). Working memory. Science, 255, 556-559.
5. Barak, Y., & Achiron, A. (2002). Effect of interferon beta 1-b on cognitive functions in multiple sclerosis. European Neurology, 47, 11-14.
6. Beatty, W. W., & Goodkin, D. E. (1990). Screening for cognitive impairment in multiple sclerosis. An evaluation of the Mini-Mental State Examination. Archives of Neurology, 47, 297-301.
7. Beatty, W. W., Goretti, B., Siracusa, G., Zipoli, V., Portaccio, E., Amato, M. P. et al. (2003). Changes in neuropsychological test performance over the workday in multiple sclerosis. Clinical Neuropsychology, 17, 551-560.
8. Benedict, R. H. B. (2005). Integrating cognitive function screening and assessment into the routine care of multiple sclerosis patients. CNS Spectrum, 10, 384-391.
9. Benedict, R. H. et al. (2008a). Scales and methods to measure cognition. Proceedings of the MS forum Modern Management Workshop (pp. 28-33). Budapest.
10. Benedict, R. H. B., Cookfair, D., Gavett, R., Gunther, R., Munschauer, F., Garg, N. et al. (2006). Validity of the Minimal Assessment of Cognitive Function in Multiple Sclerosis (MACFIMS). Journal of the International Neuropsychological Society, 12, 549-558.
11. Benedict, R. H. B., Fischer, J. S, Archibald, C. J., Annett, P. A., Beatty, W. W., Bobholz, J. et al. (2002). Minimal neuropsychological assessment of MS patients: A consensus approach. Clinical Neuropsychologist, 16, 381-397.
12. Benedict, R. H. B., Munschauer, F., Linn, R. et al. (2003). Screening for multiple sclerosis cognitive impairment using a self-administered 15-item questionnaire. Multiple Sclerosis, 9, 95-101.
13. Benedict, R. H., Munschauer, F., Zarevics, P., Erlanger, D., Rowe, V., Feaster, T. et al. (2008b). Effects of l-amphetamine sulphate on cognitive function in multiple sclerosis patients. Journal of Neurology, 255, 848-852.
14. Benedict, R. H. B., Shapiro, A., Priore, R., Miller, C., Munschauer, F., & Jacobs, L. (2000). Neuropsychological counseling improves social behavior in cognitively-impaired multiple sclerosis patients. Multiple Sclerosis, 6, 391-396.
15. Benedict, R. H. B., & Zivadinov, R. (2007). Reliability and validity of neuropsychological screening and assessment strategies in MS. Journal of Neurology, 254, 22-25.
16. Bobholz, J. A., & Rao, S. M. (2003). Cognitive dysfunction in multiple sclerosis: A review of recent developments. Current Opinion in Neurology, 16, 283-288.
17. Calabrese, P. (2006). Neuropsychology of multiple sclerosis: An overview. Journal of Neurology, 253, 10-15.
18. Charcot, J. M. (1877). Lectures on the diseases of the nervous system. London: New Sydenham Society.
19. Christodoulou, C., Melville, P., Scherl, W. F., Macallister, W. S., Elkins, L. E., Krupp, L. B. et al. (2006). Effects of donepezil on memory and cognition in multiple sclerosis. Journal of the Neurological Sciences, 245, 127-136.
20. Compston, A., & Coles, A. (2002). Multiple sclerosis. Lancet, 359, 1221-1231.
21. Demaree, H. A., Gaudino, E., & DeLuca, J. (2003). The relationship between depressive symptoms and cognitive dysfunction in multiple sclerosis. Cognitive Neuropsychiatry, 8, 161-171.
22. Denney, D. R., Sworowski, L. A., & Lynch, S. G. (2005). Cognitive impairment in three subtypes of multiple sclerosis. Archives of Clinical Neuropsychology, 20, 967-981.
23. Doraiswamy, P. M., & Rao, S. M. (2004). Treating cognitive deficits in multiple sclerosis: Are we there yet? Neurology, 63, 1552-1553.
24. Engel, C., Greim, B., & Zettl, U. K. (2007). Diagnostics of cognitive dysfunction in multiple sclerosis. Journal of Neurology, 254, 30-34.
25. Feinstein, A. (2004). The neuropsychiatry of multiple sclerosis. Canadian Journal of Psychiatry, 49, 157-163.
26. Feinstein, A. (2006). Mood disorders in multiple sclerosis and the effects on cognition. Journal of the Neurological Sciences, 245, 63-66.
27. Fischer, J. S. (2002). Assessment of neuropsychological function. In R. A. Rudick & J. A. Cohen (Eds.), Multiple Sclerosis Therapeutics. London: Martin Dunitz.
28. Fischer, J. S., Priore, R. L., Jacobs, L. D., Cookfair, D. L., Rudick, R. A., Herndon, R. M. et al. (2000). Neuropsychological effects of interferon beta 1-b in relapsing multiple sclerosis. Multiple Sclerosis Collaborative Research Group. Annals of Neurology, 48, 885-892.
29. Flacheneker, P., Kumpfel, T., Kallman, B., Cottschalk, M., Grauer, O., Rieckmann, P. et al. (2002). Fatigue in multiple sclerosis: A comparison of different rating scales and correlation to clinical parameters. Multiple Sclerosis, 8, 523-526.
30. Fowley, F. W., Dince, W. M., Bedell, N. G., LaRocca, N. G., Kalb, R., Caruso, L. S. et al. (1994). Psychoremediation of communication skills for cognitively impaired persons with multiple sclerosis. Journal of Neurological Rehabilitation, 8, 165-176.
31. Freedman, M. S. (2006). Disease-modifying drugs for multiple sclerosis: Current and future aspects. Expert Opinion in Pharmacotherapy, 7, S1-S9.
32. Gerschlager, W., Beisteiner, R., Deecke, L., Dirnberger, G., Endi, W., Kolleger, H. et al. (2000). Electrophysical, neuropsychological and clinical findings in multiple sclerosis patients receiving interferon beta-1b: A one-year follow-up. European Neurology, 44, 205-209.
33. Ghaffar, O., & Feinstein, A. (2007). The neuropsychiatry of multiple sclerosis: A review of recent developments. Current Opinion in Psychiatry, 20, 278-285.
34. Haase, C. G., Tinnefeld, M., Lienemann, M., Ganz, R. E., & Faustmann, P. M. (2003). Depression and cognitive impairment in disability free early multiple sclerosis. Behavioral Neurology, 14, 39-45.
35. Henry, J. D., & Beatty, W. W. (2006). Verbal fluency deficits in multiple sclerosis. Neuropsychologia, 44, 1166-1174.
36. Herman, M. A., Jick, S. S., Logroscino, M. J., Olek, M. J., Ascherio, A., & Jick, H. (2005). Cigarette smoking and the progression of multiple sclerosis. Brain, 128, 1461-1465.
37. Hoffman, S., Tittgemeyer, M., & Yves von Cramon, D. (2007). Cognitive impairment in multiple sclerosis. Current Opinion in Neurology, 20, 275-280.
38. Huijbregts, S. C. J., Kalkers, N. F., de Sonneville, L. M. J., De Groot., & Polman, C. H. (2006). Cognitive impairment and decline in different MS subtypes. Journal of the Neurological Sciences, 24, 187-194.
39. Huijbregts, S. C. J., Kalkers, N. F., De Sonneville, L. M. J., de Groot, V., Reuling, I. E. W., Polman, C. H. et al. (2004). Differences in cognitive impairment of relapsing remitting, secondary, and primary progressive MS. Neurology, 63, 335-339.
40. Jonsson, A., Korfitzen, E. M., Heltberg, A., Ravnborg, M. H., & Byskon-Ottosen, E. (1993). Effects of neuropsychological treatment in patients with multiple sclerosis. Acta Neurologica Scandinavia, 88, 394-400.
41. Kappos, L., Freedman, M. S., Polman, C. H. et al. (2007). Effect of early versus delayed interferon beta 1-b treatment on disability after a first clinical event suggestive of multiple sclerosis: A three-year follow-up analysis of the BENEFIT study. Lancet, 370, 389-397.
42. Krupp, L. B., Christodoulou, C., Melville, P., Scherl, W. F., MacAllister, W. S., Elkins, L. E. et al. (2004). Donepezil improved memory in multiple sclerosis in a randomized clinical trial. Neurology, 63, 1579-1585.
43. Krupp, I. B., & Elkins, L. E. (2000). Fatigue and declines in cognitive functioning in multiple sclerosis. Neurology, 55, 934-939.
44. Lazeron, R. H., Boringa, J. B., Schouten, M. et al. (2005). Brain atrophy and lesion load as explaining parameters for cognitive impairment in multiple sclerosis. Multiple Sclerosis, 11, 524-531.
45. Litvan, J., Grafman, J., Vendrell, P., Martinez, J. M., Junque, C., Vendrell, J. M. et al. (1988). Multiple memory deficits in patients with multiple sclerosis: Exploring the working memory system. Archives of Neurology, 45, 607-610.
46. Lovera, J., Bagert, B., Smoot, K., Morris, C. D., Frank, R., Bogardus, K. et al. (2007). Ginkgo biloba for the improvement of cognitive performance in multiple sclerosis: A randomized, placebo-controlled trial. Multiple Sclerosis, 13, 376-387.
47. Lynch, S. G., Parmenter, B. A., & Denney, D. R. (2005). The association between cognitive impairment and physical disability in multiple sclerosis. Multiple Sclerosis, 11, 469-476.
48. Mahler, M. E., & Benson, D. F. (1990). Cognitive dysfunction in multiple sclerosis: A subcortical dementia? In S. M. Rao (Ed.), Neurobehavioral aspects of multiple sclerosis (pp. 88-101). New York: Oxford University Press.
49. McKhann, G. M. (1982). Multiple sclerosis. Annual Review of Neuroscience, 5, 219-239.
50. Messinis, L., Anyfantis, E., Paschali, A., & Papathanasopoulos, P. (in press). Neuropsychological deficits in relapsing remitting multiple sclerosis patients with low disability status. Proceedings of the 7th International Congress on the Improvement of the Quality of life on Dementia, Parkinson's disease, Epilepsy, MS, Muscular disorders and Neuroethics. Thessaloniki, January 2009.
51. Nocentini, U., Pasqualetti, P., Bonavita, S., Buccafuscam, M., De Caro, M. F., Farina, D. et al. (2006). Cognitive dysfunction in patients with relapsing-remitting multiple sclerosis. Multiple Sclerosis, 12, 77-87.
52. Olivares, T., Nieto, A., Sanchez, M. P., Wollman, T., Hernandez, M. A., Barroso, J. et al. (2005). Pattern of neuropsychological impairment in the early phase of relapsing-remitting multiple sclerosis. Multiple Sclerosis, 11, 191-197.
53. Oliveri, R. L., Sibilia, G., Valentino, P., Russo, C., Romeo, N., & Quattrone, A. (1998). Pulsed methylprednisolone induces a reversible impairment of memory in patients with relapsingremitting multiple sclerosis. Acta Neurologica Scandinavia, 97, 366-369.
54. Ozakbas, S., Idiman, E., Kaya, D., Poyraz, T. & Poyraz, E. (2008). Effects of mitoxantrone treatment on cognitive and physical disability in patients with multiple sclerosis. Neurology, 70, 117.
55. Parry, A. M., Scott, R. B., Palace, J., Smith, S., & Mathews, P. M. (2003). Potentially adaptive functional changes in cognitive processing for patients with multiple sclerosis and their acute modulation by rivastigmine. Brain, 126, 2750-2760.
56. Patti, F. (2009). Cognitive impairment in multiple sclerosis. Multiple Sclerosis, 15, 2-8.
57. Paulesu, E., Frith, C. D., & Frackowiak, R. S. J. (1993). The neural correlates of the verbal component of working memory. Nature, 362, 342-344.
58. Pelosi, L., Geesken, J. M., Holly, M., Hayward, M., & Blunkhart, L. D. (1997). Working memory impairment in early multiple sclerosis: Evidence from an event-related potential study of patients with clinically isolated myelopathy. Brain, 120, 2039-2058.
59. Peterson, J. W., Bo, L., Mork, S., Chang, A., & Trapp, B. D. (2001). Transected neuritis, apoptic neurons, and reduced inflammation in cortical multiple sclerosis lesions. Annals of Neurology, 50, 389-400.
60. Penner, I. K., & Kappos, L. (2006). Retraining attention in MS. Journal of the Neurological Sciences, 245, 147-151.
61. Pierson, S. H., & Griffith, N. (2006). Treatment of cognitive impairment in multiple sclerosis. Behavioural Neurology, 17, 53-67.
62. Pliskin, N. H., Hamer, D. P., Goldstein, D. S., Towler, V. L., Reder, A. T., Noronha, A. et al. (1996). Improved delayed visual reproduction test performance in multiple sclerosis patients receiving interferon beta-1b. Neurology, 47, 1463-1468.
63. Plohman, A. M., Kappos, L., Ammann, W., THordai, A., Wittwer, A., Huber, S. et al. (1998). Computer assisted retraining of attentional impairments in patients with multiple sclerosis. Journal of Neurology, Neurosurgery and Psychiatry, , 64, 455-462.
64. Potagas, C., Giogkaraki, E., Koutsis, G., Mandelos, D., Tsirempolou, E., Sfagos, C. et al. (2008). Cognitive impairment in different MS subtypes and clinically isolated syndromes. Journal of the Neurological Sciences, 267, 100-106.
65. Portaccio, E., Goretti, B., Zipoli, G., Siracusa, S., & Amato, M. P. (2009). A short version of Rao's brief repeatable battery as a screening tool for cognitive impairment in multiple sclerosis. Clinical Neuropsychologist, 23, 268-275.
66. Randolph, J. J., Arnett, P. A., & Higginson, C. L. (2001). Metamemory and tested cognitive functioning in multiple sclerosis. Clinical Neuropsychologist, 15, 357-368. (Pubitemid 34025268)
67. Rao, S. M. (1986). Neuropsychology of multiple sclerosis: A critical review. Journal of Clinical and Experimental Neuropsychology, 8, 503-542. (Pubitemid 17185342)
68. Rao, S. M., Leo, G. J., Bernardin, L., & Unverzagt, F. (1991a). Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction. Neurology, 41, 685-691.
69. Rao, S. M., Leo, G. J., Ellington, L., Nauertz, T., Bernardin, L., & Unverzagt, F. (1991b). Cognitive dysfunction in multiple sclerosis. II. Impact on employment and social functioning. Neurology, 41, 692-696.
70. Rao, S. M. (1995). Neuropsychology of multiple sclerosis. Current Opinion in Neurology, 8, 216-220.
71. Rocca, M. A., Falini, A., Colombo, B., Rossi, P., Comi, G., Filippi, M. et al. (2002). Adaptive functional changes in the cerebral cortex of patients with nondisabling multiple sclerosis correlate with the extent of brain structural damage. Annals of Neurology, 51, 330-339. (Pubitemid 34206289)
72. Rogers, J. M., & Panegyres, P. K. (2007). Cognitive impairment in multiple sclerosis: Evidence-based analysis and recommendations. Journal of Clinical Neurosciences, 14, 919-927. (Pubitemid 47333187)
73. Rovaris, M., Filippi, M., Falautano, L. et al. (1998). Relation between MR abnormalities and patterns of cognitive impairment in multiple sclerosis. Neurology, 50, 1601-1608. (Pubitemid 28283224)
74. Ruggieri, R. M., Palermo, R., Vitello, G., Gennusco, M., Settipani, N., & Piccoli, F. (2003). Cognitive impairment in patients suffering from relapsimg-remitting multiple sclerosis with EDSS53.5. Acta Neurologica Scandinavia, 108, 323-326. (Pubitemid 37357635)
75. Sartori, E., & Edan, G. (2006). Assessment of cognitive dysfunction in multiple sclerosis. Journal of Neurological Sciences, 245, 169-175. (Pubitemid 43775946)
76. Schwid, S. R., Tyler, C. M., Scheid, E. A., Weinstein, A., Goodman, A. D., McDermott, M. P. et al. (2003). Cognitive fatigue during a test requiring sustained attention: A pilot study. Multiple Sclerosis, 9, 503-508. (Pubitemid 37287731)
77. Schwid, S. R., Goodman, A. D., Weinstein, A., McDermott, M. P., & Johnson, K. P. (2007). Cognitive function in relapsing remitting multiple sclerosis: Minimal changes in a 10-year clinical trial. Journal of the Neurological Sciences, 255, 57-63. (Pubitemid 46414020)
78. Schulz, D., Kopp, B., Kunkel, A., & Faiss, J. H. (2006). Cognition in the early stages of multiple sclerosis. Journal of Neurology, 253, 1002-1010. (Pubitemid 44441123)
79. Sohlberg, M. M., & Mateer, C. A. (2001). Cognitive Rehabilitation: An integrative neuropsychological approach. New York: Guilford Press.
80. Staffen, W. A., Mair, H., Zauner, A., Unterrainer, J., Niederhofer, H., Kuttzeluigg, A. et al. (2002). Cognitive function and fMRI in patients with multiple sclerosis: Evidence for compensatory cortical activation during an attention task. Brain, 125, 1275-1282. (Pubitemid 34587137)
81. Strober, L. B., Englert, J. J., Alt, M., Munschauer, F., Weinstock-Guttman, B., Benedict, R. H. et al. (2008). Comparing the sensitivity of memory tests in multiple sclerosis (MS): The Rao Brief Repeatable Neuropsychological Battery (BRNB) and the Minimal Assessment of Cognitive Function in MS (MACFIMS). Abstract, Journal of the International Neuropsychological Society, 36th Annual Meeting, February 6-9.
82. Waikoloa, Hawaii. Weinstein, A., Scwid, S. R., Schiffer, R. B., McDermott, M. P., Giang, D. W., Goodman, A. D. et al. (1999). Neuropsychologic status in multiple sclerosis after treatment with glatiramer. Archives of Neurology, 56, 319-324. (Pubitemid 29120229)
83. Vogt, A., Kappos, L., Calabrese, P., Stocklin, M. N., Geschwind, L., Opwis, K. et al. (2009). Working memory training in patients with multiple sclerosis - Comparison of two different training schedules. Restorative Neurology and Neurosciences, 27, 225-235.
84. Zakzanis, K. K. (2000). Distinct neurocognitive profiles in multiple sclerosis subtypes. Archives of Clinical Neuropsychology, 15, 115-136.
85. Zephir, H., de Seze, J., Dujardin, K., Dubois, G., Cabaret, M., Bouillauet, S. et al. (2005). One year cyclophosphamide treatment combined with methylprednisolone improves cognitive dysfunction in progressive forms of multiple sclerosis. Multiple Sclerosis, 11, 360-363. (Pubitemid 40775196)
86. Zivadinov, V. R., De Masi, D., Nasuelli, L. M., Monti Bragadin, L., Ukmar, M., Pozzi Mucceli, R. S. et al. (2001). MRI techniques and cognitive impairment in the early phase of relapsing-remitting multiple sclerosis. Neuroradiology, 43, 272-278. (Pubitemid 32288471)